Ovarian cancer relies on the PDGFRβ–fibronectin axis for tumorsphere formation and metastatic spread

Author:

Gendrau‐Sanclemente Núria12ORCID,Figueras Agnès12,Gracova Kristina12,Lahiguera Álvaro12,Alsina‐Sanchís Elisenda12,Marín‐Jiménez Juan A.34ORCID,Vidal August256ORCID,Matias‐Guiu Xavier256,Fernandez‐Gonzalez Sergi7,Barahona Marc7,Martí Lola7,Ponce Jordi7,Viñals Francesc128ORCID

Affiliation:

1. Program Against Cancer Therapeutic Resistance (ProCURE) Catalan Institute of Oncology (ICO), Hospital Duran i Reynals Barcelona Spain

2. Oncobell Program Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) Barcelona Spain

3. Cancer Immunotherapy (CIT) Group‐ProCURE Bellvitge Biomedical Research Institute (IDIBELL) – OncoBell Barcelona Spain

4. Department of Medical Oncology Catalan Institute of Oncology (ICO) Barcelona Spain

5. Department of Pathology University Hospital of Bellvitge (IDIBELL) Barcelona Spain

6. CIBERONC Instituto de Salud Carlos III Madrid Spain

7. Department of Gynaecology University Hospital of Bellvitge (IDIBELL) Barcelona Spain

8. Departament de Ciències Fisiològiques Universitat de Barcelona Spain

Abstract

High‐grade serous ovarian cancer (HGSOC) is the deadliest gynecological malignancy. The most common form of metastatic spread of HGSOC is transcoelomic dissemination. In this process, detached cells from the primary tumor aggregate as tumorspheres and promote the accumulation of peritoneal ascites. This represents an early event in HGSOC development and is indicative of poor prognosis. In this study, based on tumorspheres isolated from ascitic liquid samples from HGSOC patients, ovarian cancer spheroid 3D cultures, and in vivo models, we describe a key signal for tumorsphere formation in HGSOC. We report that platelet‐derived growth factor receptor beta (PDGFRβ) is essential for fibronectin‐mediated cell clustering of ovarian cancer cells into tumorspheres. This effect is mediated by the kinase NUAK family SNF1‐like kinase 1 (NUAK1) and blocked by PDGFRβ pharmacological or genetic inhibition. In the absence of PDGFRβ, ovarian cancer cells can be provided with fibronectin by cancer‐associated fibroblasts to generate chimeric spheroids. This work provides new insights that uncover potential targets to prevent peritoneal dissemination, the main cause of advanced disease in HGSOC patients.

Funder

Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya

Ministerio de Ciencia e Innovación

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Reference45 articles.

1. The genesis and evolution of high-grade serous ovarian cancer

2. High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints

3. The Transcoelomic Ecosystem and Epithelial Ovarian Cancer Dissemination

4. Ovary SEER survival rates by time since diagnosis 2000‐2017.NIH Surveillance Epidemiology and End Results Program (SEER). [cited 2023 Aug 01]. Available from:www.seer.cancer.gov

5. Ovarian cancer: strategies for overcoming resistance to chemotherapy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3